Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma.

Nakaji H, Petrova G, Matsumoto H, Iwata T, Ito I, Oguma T, Inoue H, Tajiri T, Nagasaki T, Kanemitsu Y, Niimi A, Mishima M.

Ann Allergy Asthma Immunol. 2013 Mar;110(3):198-203.e3. doi: 10.1016/j.anai.2012.12.016. Epub 2013 Jan 29.

PMID:
23548532
2.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
3.

The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.

Fritscher LG, Rodrigues MT, Zamel N, Chapman KR.

Respir Med. 2009 Feb;103(2):296-300. doi: 10.1016/j.rmed.2008.08.007. Epub 2008 Sep 20.

4.

A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.

Strauch E, Moske O, Thoma S, Storm Van's Gravesande K, Ihorst G, Brandis M, Kuehr J.

Pediatr Res. 2003 Aug;54(2):198-203. Epub 2003 May 7.

PMID:
12736396
5.

Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma.

Hoshino M.

Allergol Int. 2010 Mar;59(1):59-66. doi: 10.2332/allergolint.09-OA-0122. Epub 2009 Dec 25.

6.

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.

Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA; Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group.

Thorax. 2003 Mar;58(3):211-6.

7.

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.

Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.

J Allergy Clin Immunol. 2005 Feb;115(2):233-42.

PMID:
15696076
8.

Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.

Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS; MIAMI Study Research Group.

J Allergy Clin Immunol. 2007 Apr;119(4):916-23. Epub 2007 Mar 8.

PMID:
17349681
9.

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.

Dupont L, Potvin E, Korn D, Lachman A, Dramaix M, Gusman J, Peché R; Singulair as Complementary Therapy to Fixed Association in Real life Study Group.

Curr Med Res Opin. 2005 Jun;21(6):863-9.

PMID:
15969886
10.

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J.

Clin Exp Allergy. 2001 Jun;31(6):845-54.

PMID:
11422148
11.

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.

Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.

Ann Intern Med. 1999 Mar 16;130(6):487-95.

PMID:
10075616
12.

Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment.

Hung CH, Jong YJ, Hua YM, Li CY, Lai YS, Yang KD, Chang HC.

Pulm Pharmacol Ther. 2007;20(3):233-9. Epub 2006 Apr 20.

PMID:
17276712
13.

Combined mediator blockade or topical steroid for treating the unified allergic airway.

Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ.

Allergy. 2007 Jan;62(1):73-80.

14.

Single-dose desloratadine and montelukast and allergen-induced late airway responses.

Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW.

Eur Respir J. 2009 Jun;33(6):1302-8. doi: 10.1183/09031936.00169008. Epub 2009 Jan 22.

15.

The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.

Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N.

Turk J Pediatr. 2009 Sep-Oct;51(5):460-5.

PMID:
20112601
16.

Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.

Ghiro L, Zanconato S, Rampon O, Piovan V, Pasquale MF, Baraldi E.

Eur Respir J. 2002 Sep;20(3):630-4.

17.

Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.

Kanniess F, Richter K, Janicki S, Schleiss MB, Jörres RA, Magnussen H.

Eur Respir J. 2002 Nov;20(5):1080-7.

19.

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.

Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A.

Thorax. 2008 May;63(5):453-62. doi: 10.1136/thx.2007.081596. Review.

PMID:
18443162
20.

Ciclesonide therapy in asthma: a potential effect on small airway inflammation?

Antoniu SA, Monica Pop C.

Expert Opin Pharmacother. 2009 Apr;10(5):917-9. doi: 10.1517/14656560902824160 .

PMID:
19351238

Supplemental Content

Support Center